David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
176
DELISTED
Interxion Holding N.V.
INXN
| $72.5M | 0.13% |
2,096,475
+232,009
| +12% | +$7.22M |
|
177
CALL
Procter & Gamble
PG
$336B
| $72.4M | 0.13% |
879,600
+14,900
| +2% | +$1.2M |
|
178
PUT
RTX Corp
RTX
$283B
| $72.1M | 0.13% |
1,144,080
-194,653
| -15% | -$11.3M |
|
|
WFM
179
DELISTED
Whole Foods Market Inc
WFM
| $72M | 0.13% |
2,314,196
-218,431
| -9% | -$6.84M |
|
|
180
PUT
Citigroup
C
$221B
| $71.8M | 0.13% |
1,720,200
+749,200
| +77% | +$31.3M |
|
181
Edgewell Personal Care
EPC
$1.32B
| $71.6M | 0.13% |
889,027
+269,743
| +44% | +$20.7M |
|
182
Cisco
CSCO
$438B
| $71.6M | 0.13% |
2,514,548
+811,367
| +48% | +$20.9M |
|
183
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $70.8M | 0.13% |
196,300
-25,800
| -12% | -$10.6M |
|
184
CALL
Bausch Health
BHC
$2.41B
| $70.7M | 0.13% |
2,686,900
+9,900
| +0.4% | +$732K |
|
185
Cardinal Health
CAH
$53.4B
| $70.5M | 0.13% |
859,947
+629,709
| +274% | +$51.2M |
|
|
186
CALL
Gilead Sciences
GILD
$181B
| $70.3M | 0.13% |
765,100
-17,500
| -2% | -$1.58M |
|
187
Corning
GLW
$129B
| $70.1M | 0.13% |
3,353,556
-2,220,959
| -40% | -$41.2M |
|
188
Willis Towers Watson
WTW
$31.8B
| $69.2M | 0.12% |
583,279
+14,560
| +3% | +$1.68M |
|
189
CALL
AT&T
T
$173B
| $69.2M | 0.12% |
2,338,846
+1,678,038
| +254% | +$46.5M |
|
190
PUT
Walt Disney
DIS
$186B
| $69.1M | 0.12% |
696,300
-33,200
| -5% | -$3.21M |
|
191
Trimble
TRMB
$14B
| $68.6M | 0.12% |
2,765,192
-1,432,296
| -34% | -$31.6M |
|
192
CALL
Humana
HUM
$45.5B
| $67.7M | 0.12% |
370,000
+207,000
| +127% | +$35.9M |
|
193
Keurig Dr Pepper
KDP
$43.6B
| $67.5M | 0.12% |
754,830
+563,205
| +294% | +$51.4M |
|
194
CALL
Intel
INTC
$476B
| $67.4M | 0.12% |
2,083,100
+68,500
| +3% | +$2.1M |
|
195
CALL
Chipotle Mexican Grill
CMG
$46.7B
| $67.1M | 0.12% |
7,125,000
-1,975,000
| -22% | -$18.8M |
|
196
CALL
Microsoft
MSFT
$3.59T
| $67M | 0.12% |
1,213,800
-1,131,300
| -48% | -$59.3M |
|
197
American Electric Power
AEP
$65.8B
| $66.9M | 0.12% |
1,008,058
+203,134
| +25% | +$12.6M |
|
198
Ameriprise Financial
AMP
$49.1B
| $66.9M | 0.12% |
711,408
+170,326
| +31% | +$15.3M |
|
199
Canadian National Railway
CNI
$78.5B
| $66.7M | 0.12% |
1,067,771
-174,939
| -14% | -$9.8M |
|
200
AerCap
AER
$23B
| $66.7M | 0.12% |
1,721,398
-1,810,446
| -51% | -$62.3M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.